Literature DB >> 18600244

Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study.

A Fotouhi1, H Hashemi, M Khabazkhoob, K Mohammad.   

Abstract

PURPOSE: To determine the prevalence and causes of pterygium and pinguecula in the population of Tehran in 2002.
METHODS: In a cross-sectional population study with cluster sampling, 6497 residents of Tehran were selected from 160 clusters. Samples were chosen according to a door-to-door head counting and were then invited for free examinations. After the interview, ophthalmic examinations were performed at an eye clinic.
RESULTS: Of the selected sample, 4564 people (70.3%) participated in the study. The age- and gender-standardized prevalence of pterygium in this population was 1.3% (95% confidence interval (CI): 0.9-1.6%). The prevalence of pterygium was 1.4 and 1.1% in men and women, respectively (P>0.05). The prevalence of pinguecula in this study was 22.5% (95% CI: 21.1-24.0%); 27.1% in men and 17.7% in women (P<0.001). In both genders, the prevalence of pterygium and pinguecula showed a significant increase with age (P<0.001).
CONCLUSIONS: This study concerns the status of pterygium and pinguecula according to age and gender in the population of Tehran. The overall prevalence rates were 1.3 and 22.5% for pterygium and pinguecula, respectively. The comparison of the results with those reported from other areas of the world suggests lower prevalence rates in Tehran.

Entities:  

Mesh:

Year:  2008        PMID: 18600244     DOI: 10.1038/eye.2008.200

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

Review 1.  [Epidemiology of pterygium. A review].

Authors:  K Droutsas; W Sekundo
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  Prevalence of pinguecula and pterygium in a general population in Spain.

Authors:  E Viso; F Gude; M T Rodríguez-Ares
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

3.  Risk Factors for Pterygium in Ilam Province, Iran.

Authors:  Parviz Malekifar; Hamed Esfandiari; Nazanin Behnaz; Fatemeh Javadi; Sima Azish; Mohammad Ali Javadi; Masumeh Kalantarion
Journal:  J Ophthalmic Vis Res       Date:  2017 Jul-Sep

4.  Relationship between pinguecula formation and exposure to tandoor ovens in a hospital-based study.

Authors:  Adem Gul; Hasan Goker; Senol Sabanci; Ali Kurt; Kemal Turkyilmaz
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

5.  Prevalence and associated factors for pterygium in a Chinese rural population with type 2 diabetes in a cross-sectional study: Jiangsu Diabetic Eye Disease Study (JDEDS).

Authors:  Junfang Zhang; Bai Qin; Bihong Liu; Dajun Sun; Congkai Liang; Shiyi Wang; Mei Yang; Rongrong Zhu
Journal:  Int Ophthalmol       Date:  2022-08-10       Impact factor: 2.029

6.  Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, single-centre investigation.

Authors:  Naser Samadi Aidenloo; Qader Motarjemizadeh; Maryam Heidarpanah
Journal:  Jpn J Ophthalmol       Date:  2018-03-16       Impact factor: 2.447

Review 7.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

8.  Ocular findings in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Priscilla Magalhães; Newton Kara-Junior; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Inferior conjunctival autografting for pterygium surgery: an alternative way of preserving the glaucoma filtration site in far western Nepal.

Authors:  Arjun Shrestha; Anand Shrestha; Sujata Bhandari; Nhukesh Maharjan; Deepak Khadka; Suresh Raj Pant; Bidya Prasad Pant
Journal:  Clin Ophthalmol       Date:  2012-03-01

10.  The prevalence of pterygium in Alkhobar: A hospital-based study.

Authors:  Jerman M Alqahtani
Journal:  J Family Community Med       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.